Age, BRAF status, categorical LDH group, ECOG performance status, metastatic stage, melanoma subtype, and line of therapy all were retained in the model at p<0.15 in both analyses, with and without adjustment for classifier prediction (Supplementary Table 1). The gene discussed is BRAF; the disease is melanoma.